Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see AMPLIA THERAPEUTICS LIMITED →Already a subscriber? Sign in
Xcout Intel tracks AMPLIA THERAPEUTICS LIMITED continuously — this profile deepens as new filings, funding, people and hiring data arrive.